John Paulson’s Insmed INSM Stock Holding History

John Paulson’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-90,000	Closed	-$1.58M	–	115
2017 Q1	$1.58M	Sell	90,000 -115,200	-56%	-$1.78M	0.02%	86
2016 Q4	$2.71M	Hold	205,200	–	–	0.03%	82
2016 Q3	$2.98M	Hold	205,200	–	–	0.03%	80
2016 Q2	$2.02M	Hold	205,200	–	–	0.02%	75
2016 Q1	$2.6M	Buy	205,200 +40,000	+24%	+$526K	0.02%	78
2015 Q4	$3M	Buy	+165,200	New	+$2.91M	0.02%	64

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

John Paulson's INSM Position: Q2 2017 in Review

John Paulson sold out of Insmed (INSM) in Q2 2017, closing a stake of 90,000 shares — an estimated $1.58M sold.

John Paulson first reported a position in INSM in Q4 2015 and held it in 6 quarters. The position peaked at $3M in Q4 2015. 114 funds tracked by Wall St. Rank hold INSM as of Q2 2017.

John Paulson reported no remaining Insmed position as of Q2 2017 after selling out during the quarter.
John Paulson sold 90,000 Insmed shares in Q2 2017, an estimated $1.58M.
John Paulson first reported a position in Insmed in Q4 2015 and held it in 6 quarters.
John Paulson's Insmed position peaked at $3M in Q4 2015.
114 funds tracked by Wall St. Rank held Insmed as of Q2 2017.

Based on Paulson & Co's 13F filing for Q2 2017, filed 14 Aug 2017.